A study in Brazil examines the spiritual well-being of psychedelic users and non-users, revealing distinct experiences and emphasizing the need for inclusive spirituality assessment tools.
Doxycycline, an antibiotic, shows promise in reducing addictive effects of drugs like morphine and cocaine, offering new treatment avenues for substance use disorders. These findings, though preliminary and based on male mice, suggest potential for more effective interventions against addiction.
Psilocybin-assisted group therapy might help reduce depression in cancer patients. This innovative approach, blending psychedelic effects with psychological support, has demonstrated promising results in improving mental health and quality of life for these patients.
Despite high hopes, a recent study reveals that a 300mg dose of cannabidiol fails to alleviate cognitive anxiety symptoms, challenging its perceived anxiolytic benefits and prompting a reevaluation of its therapeutic potential. The study was published in Psychopharmacology.
A new study shows how depression alters brain connectivity, particularly in the habenula, and how ketamine treatment reverses these changes. This research enhances understanding of depression and ketamine's rapid antidepressant effects.
New research published in Scientific Reports provides insights into the long-term negative psychological effects of psychedelic drugs. The study helps to identify potential risk factors for persistent anxiety, panic, and other psychological issues following the use of substances such as...
Researchers have discovered significant differences in white matter between regular cannabis users and non-users, indicating potential impacts on brain function. The findings highlight the need for further investigation into cannabis's effects on neurodevelopment.
Scientists at Enveric Biosciences have created novel psilocybin derivatives, potentially offering therapeutic mental health benefits with reduced psychedelic effects. This research paves the way for new treatments for depression and anxiety.
Research from Toronto Western Hospital shows psilocybin-assisted psychotherapy as a promising treatment for major depression and cancer-related distress, calling for urgent advanced clinical trials. This innovative approach combines psychedelic mushrooms with guided therapy, offering new hope in mental health.
Recent research reveals how brain circuits respond differently to drug delivery methods, with rapid dopamine increases significantly impacting addiction-related neural pathways. The study offers new insights into addiction treatment strategies.
New research suggests a single dose of psilocybin, combined with psychotherapy, could significantly reduce depression in individuals with bipolar II disorder, maintaining these effects for 12 weeks. This innovative approach, contrasting sharply with self-medication, highlights the potential of controlled psychedelic...
A new study shows that chronic ketamine exposure causes major changes in mice brains, particularly in the dopamine system, which is crucial for mood and motivation. The study, published in Cell Reports, highlights ketamine's complex effects on brain regions, indicating...
Exploring the mind-bending realm of drug-induced time warps, scientists have delved into how substances like cocaine, MDMA, and cannabis drastically alter our perception of time, shedding light on the potential for controlled temporal experiences.
A study in the Journal of Affective Disorders found that women currently on birth control pills have a lower major depression prevalence than those who've stopped. The findings highlight complex relationships between pill use and depression, with no significant difference...
A recent study found that individuals with ADHD have reduced motivation for effortful tasks, which can be significantly improved with amphetamine-based medications. This shifts the understanding of ADHD beyond traditional symptoms to include motivational challenges.